A5030584743- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Economics and Policy
- Healthcare Policy and Management
- Blood Pressure and Hypertension Studies
- Hepatitis C virus research
- Prenatal Substance Exposure Effects
- Opioid Use Disorder Treatment
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Maternal Mental Health During Pregnancy and Postpartum
- Chronic Disease Management Strategies
- Inflammatory mediators and NSAID effects
- Primary Care and Health Outcomes
- Diabetes Management and Research
- Diabetes Management and Education
- Liver Disease Diagnosis and Treatment
- Health Policy Implementation Science
- Diabetes Treatment and Management
- Multiple and Secondary Primary Cancers
- Pharmaceutical industry and healthcare
- Pharmaceutical studies and practices
- Substance Abuse Treatment and Outcomes
- Cardiac Health and Mental Health
University of Maryland, Baltimore
2016-2025
Providence Hospital
2025
University of Baltimore
2003-2023
Behavioral Health Services
2022
Maryland Department of Health
2016
University of Maryland, College Park
2005-2014
Bayer (United States)
2012
Research Triangle Park Foundation
2008
Analysis Group (United States)
2008
University of Chicago
2006
Background In this partially randomised intervention study, we assessed the effect of social networks on improvement type 2 diabetes management in a largely African–American population Baltimore. Methods Patients group (n=68) were asked to recruit peers, form small groups, and attend monthly education sessions, emphasising peer support. control (n=70) recruited individually standard sessions. The primary outcomes changes haemoglobin A1C (HbA 1c ) blood glucose. Secondary included pressure,...
Maternal misuse of prescription opioids and illicit drugs such as, heroin non-pharmaceutical fentanyl analogs has increased in the last 2 decades one 5 women reported opioids. Medications for opioid use disorder (MOUD) are recommended treating pregnant with (OUD). MOUD is effective reducing cravings negative outcomes, yet treatment underutilized varies integration intensity resources across health systems. Exploring perceptions delivery among pregnant/parenting promises to uncover address...
To compare persistence, switching, and discontinuation rates among patients taking brand-name selective serotonin reuptake inhibitors (SSRIs).Retrospective cohort study. Data Source. Protocare Sciences managed care database.A total of 14,933 with depression, posttraumatic stress disorder, or social anxiety disorder whose prescriptions for SSRIs were filled from January 1, 1999-June 30, 2002.A 5598 received sertraline, 4131 citalopram, 5204 paroxetine. Adherence status was categorized as...
Objective. To examine racial and ethnic disparities in new prescription drug use. Data Sources/Study Setting. Secondary data analyses of the Medical Expenditure Panel Survey (1996–2001), a national survey representative U.S. noninstitutionalized civilian population. Drug approval dates were from GenRx database Mosby. Study Design. A negative binomial model was used to compare annual number times when drugs obtained across groups. Covariates demographic, economic characteristics, health...
Antidepressants are one of the most commonly prescribed classes psychotropic medications among US youths. For adults, there is emerging evidence on increased risk type 2 diabetes in association with antidepressant use. However, little known about treatment-emergent youths.To assess between use and incident youths by subclass according to duration use, cumulative dose, average daily dose.A retrospective cohort study was conducted using Medicaid claims data from 4 geographically diverse, large...
Background:The differential effects of selective cyclooxygenase-2 (COX-2) inhibitors compared with nonspecific nonsteroidal anti-inflammatory agents (NSAIDs) on platelet aggregation and prostacyclin/thromboxane balance have led to concerns that COX-2 may increase the risk for cardiovascular thrombotic events.Empirical studies generally been limited analyses secondary end points low event rates in clinical trials single observational studies, all which come conflicting conclusions.This cohort...